商铺首页
公司详情
产品陈列室
公司动态
联系方式
基本信息
企业名称
青岛君之道生物技术有限公司
企业地址
山东省青岛市山东省青岛市黄岛区双珠路136号麟瑞商务广场1栋1单元2308
成立日期
2012
企业规模(人)
50至59
年销售额(USD)
500,000至999,999
企业简介
青岛君之道生物技术有限公司一家集研发、生产、销售于一体的高科技医药化学品工厂,致力于原料药及其中间体,精细化工品研发,生产和销售。主要产品包括多佐胺中间体,布林佐胺中间体,奥洛他定中间体,西洛多辛中间体,阿派沙班中间体,马西替坦中间体,伊伐布雷定中间体等。
主要竞争优势
品牌,国际认证/标准,经验丰富的研发人员,发货速度,生产能力,产品线丰富,接受买家的规格要求,接受小额订单,良好的信誉,优质服务
邮政编码
266400
贸易信息
业务类型
制造商,出口商
主要销售市场
北美洲,中/南美洲,西欧,东欧,大洋洲,中东,非洲,亚洲
主营产品类别
原料药,中间体,生物制品
合同定制与外包服务
CRO
产品外销比重
90%
产品内销比重
10%
参展信息
主营产品
2-Mercaptothiophene;(3S)-3-(2-thienylthio)butanoic acid;(6S)-5,6-Dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-one;(6S)-5,6-Dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-one 7,7-dioxide;(4R,6S)-5,6-Dihydro-4-hydroxy-6-methylthieno[2,3-b]thiopyran-7,7-dioxide;(4S,6S)-5,6-Dihydro-4-hydroxy-6-methylthieno[2,3-b]thiopyran-7,7-dioxide;N-[(4S,6S)-6-Methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-4-yl]acetamide;N-[(4S,6S)-6-Methyl-7,7-dioxo-2-sulfamoyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-4-yl]acetamide;Dorzolamide HcL;null;3-Acetyl-2,5-dichlorothiophene;3-acetyl-5-chlorothiophene-2-sulfonamide;3-(Bromoacetyl)-5-chloro-2-thiophenesulfonamide;Hydroxylamine-O-sulfonic acid;(S)-3,4-Dihydro-6-chloro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine-1,1-dioxide;(S)-3,4-Dihydro-4-hydroxy-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide;Brinzolamide;Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate;3-Chloro-5,6-dihydro-1-(4-nitrophenyl)-2(1H)-pyridinone;5,6-Dihydro-3-(4-morpholinyl)-1-(4-nitrophenyl)-2(1H)-pyridinone;5,6-Dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl)phenyl]-2(1H)-pyridinone;1-(4-Aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1H)-pyridinone;Apixaban;N-Propylsulfamide;N-Propylsulfamide Potassium salt;5-[4-bromophenyl]-4,6-Dichloropyrimidine;5-Bromo-2-chloropyrimidine;Sulfamide, N-(phenylmethyl)-, potassium salt;Macitentan;null;2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate;1-[3-(Benzoyloxy)propyl]-2,3-dihydro-5-(2-nitropropyl)-1H-indole-7-carbonitrile;5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate;Silodosin;6-(3,4-Diaminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone;Benzamide,N-[2-amino-4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-4-methoxy-;Pimobendan;5-Hydroxy-1-tetralone;5-(2R)-2-Oxiranyl-8-benzyloxy-2(1H)-quinolinone;8-Benzyloxy-5-(2-bromoacetyl)-2-hydroxyquinoline;5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride;4-Methylthiazole-5-carboxaldehyde;6,11-Dihydro-11-oxodibenz[b,e]oxepin-2-acetic acid;[3-(Dimethylamino)propyl]triphenylphosphonium bromide hydrobromide;Olopatadine Hydrochloride;(1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane hydrochloride;7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one;Ivabradine;(2S)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester;1-(3-Methyl-1-phenyl-5-pyrazolyl)piperazine;3-[[(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]carbonyl]-thiazolidine hydrobromide (2:5);4-(2-methylphenyl)-6-(4-methylpiperazin-1-yl)pyridine-3-carboxamide;N-tert-Butyl-6-chloro-4-(o-tolyl)nicotinamide;2-(3,5-Bis-trifluoromethyl-phenyl)-2-methyl-propionic acid;Netupitant;(±)-5,6-Difluoro-1,2,3,4-tetrahydroquinaldine;8,9-Difluoro-5-methyl-6,7-dihydro-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid;Nadifloxacin;2-(3-Amino-4-chloro-benzoyl)benzoic acid;2-[4-chloro-3-(chlorosulphonyl)benzoyl]benzoic acid;Benzhydrylimine;1-Amino-1-cyclopropanecarbonitrile hydrochloride;Ethyl 2,4-dihydroxy-6-methylnicotinate;(4-methoxy-6-methyl-2-phenylmethoxypyridin-3-yl)methanol;Ethyl 8-bromooctanoate;Carsalam;Salcaprozate sodium;2-Chloro-1,3-bis(dimethylamino)trimethinium hexafluorophosphate;N-[(2Z)-2-chloro-3-(dimethylamino)prop-2-en-1-ylidene]-N-methylmethanaminium hexafluorophosphate;2-(4-Mesylphenyl)-1-(6-Methylpyridin-3-yl)-ethan-1-one;1-Aminocyclopropanecarboxylic acid;1-aminocyclopropane-1-carboxylic acid methyl este;Ethyl 1-aminocyclopropanecarboxylate hydrochloride;4-Difluoromethoxy-3-hydroxybenzaldehyde;Cyclopropyl methyl bromide;4-Amino-3,5-dichloropyridine;Sovilnesib;Baloxavir Marboxil;(R)-7-(benzyloxy)- 3,4,12,12a-tetrahydro- 1H-[1,4]oxazino[3,4- c]pyrido[2,1-f][1,2,4]- triazine-6,8-dione;3-(Benzyloxy)-4-oxo-4h-pyran-2-carboxylic acid;7,8-Difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-ol;3,6-Dihydro-2H-pyran-4-boronic acid pinacol ester;Letermovir;2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-oxo-1,2,3,4-tetrahydroquinazolin-4-yl) acetic acid methyl ester;1-(3-Methoxyphenyl)piperazine hydrochloride;2-(4-methanesulfonylphenyl)oxirane;1-(4-(methylsulfonyl)phenyl)-2-(propylamino)ethan-1-ol;2-Bromo-1-[4-(methylsulfonyl)phenyl]-1-ethanone;4-Methylthio-alpha-bromoacetophenone;Ivacaftor;2,4-Di-Tert-Butyl-5-Nitrophenyl Methyl Carbonate;4-Oxo-1,4-dihydroquinoline-3-carboxylic acid;5-Amino-2,4-di-tert-butylphenol;Olaparib;2-Fluoro-5-((3-Oxoisobenzofuran-1(3h)-Ylidene)Methyl)Benzonitrile;Orforglipron;L-Alaninol;N-Boc-L-Alaninol;Ethyl 5-Bromoindole-2-carboxylate;(2S)-Tert-Butyl 3-Cyano-2-Methyl-4-Oxopiperidine-1-Carboxylate;(R)-4-Methyl-1,3,2-dioxathiolane 2,2-dioxide;Di-tert-butyl 1-(4-fluoro-3,5-dimethylphenyl)hydrazine-1,2-dicarboxylate;5-Bromo-4-fluoro-1-methyl-1H-indazole;(4-Fluoro-3,5-dimethylphenyl)hydrazine hydrochloride;Tert-Butyl (S)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-3-(2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-Carboxylate;2H-Imidazol-2-one, 1-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-4,5,6,7-tetrahydro-4-methyl-2H-pyrazolo[4,3-c]pyridin-3-yl]-3-(4-fluoro-1-methyl-1H-indazol-5-yl)-1,3-dihydro-;1H-Indole-2-carboxamide, N-methyl-N-phenyl-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-;1H-Indole-2-carboxamide, 1-[(1S,2S)-1-cyano-2-methylcyclopropyl]-N-methyl-N-phenyl-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-;5-[(S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl]-1-[(1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl]-1H-indole-2-carboxylic Acid;2H-Imidazol-2-one, 1-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-4,5,6,7-tetrahydro-4-methyl-2H-pyrazolo[4,3-c]pyridin-3-yl]-3-(4-fluoro-1-methyl-1H-indazol-5-yl)-1,3-dihydro-;(3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester;N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl] carbamic acid ethyl ester;(1R,2R)-2-methoxycyclobutan-1-amine hydrochloride;2-Chloro-5-Cyclopropylpyrimidine;Cyclopropanol;(R)-4-N-Boc-piperazine-2-carboxylic acid methyl ester;4,4,4-Trifluoro-1-(2-Furyl)-1,3-Butanedione;5-(2-fluoro-4-hydroxyphenyl)-1H-Pyrrole-3-carbonitrile;2'-Fluoro-4'-hydroxyacetophenone;2-Bromo-1-(2-fluoro-4-hydroxyphenyl)ethanone;Ethyl 3,3-difluorocyclobutanecarboxylate;3,3-Difluoroazetidine Hydrochloride;1-(4-bromo-5-fluoro-2-hydroxyphenyl)ethanone;Methyl 4,6-dichloronicotinate;2-Bromo-5-fluoroanisole;1,1'-(Bicyclo[1.1.1]pentane-1,3-diyl)diethanone;Bicyclo[1.1.1]pentane-1,3-dicarboxylic acid;Tert-butyl N-(3-{[(tert-butoxy)carbonyl]amino}bicyclo[1.1.1]pentan-1-yl)carbamate;Bicyclo[1.1.1]pentane-1,3-diamine dihydrochloride;Tert-butyl N-{3-aminobicyclo[1.1.1]pentan-1-yl}carbamate;DiMethyl bicyclo[1.1.1]pentane-1,3-dicarboxylate;Bicyclo[1.1.1]pentane-1,3-dicarboxylic acid, MonoMethyl ester;Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-[[(1,1-diMethylethoxy)carbonyl]aMino]-, Methyl ester;3-[(Tert-Butoxycarbonyl)Amino]Bicyclo[1.1.1]Pentane-1-Carboxylic Acid;(3-tert-Butoxycarbonylamino-bicyclo[1.1.1]pent-1-yl)-carbamic acid benzyl ester;Carbamic acid, N-(3-aminobicyclo[1.1.1]pent-1-yl)-, phenylmethyl ester;3-Fluorobicyclo[1.1.1]pentane-1-carboxylicacid;Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-amino-, hydrochloride
参展展会
第二十三届世界制药原料中国展
展会时间
2025-03-06至2025-07-31
展位号
W3D32g
展品分类
Intermediates & Fine Chemicals;CMO & CRO
参展信息
×